Latest news
Moleculin reports promising preliminary phase II/III data for leukaemia drug Annamycin - Indian Pharma PostIndian Pharma Post · Tue, 04 Aug 2026 13:56:06 GMTRhythm Pharmaceuticals Reports Preliminary Phase 2 RM-718 Data in Acquired Hypothalamic Obesity; Hosts Q2 2026 Conference Call - Quiver QuantitativeQuiver Quantitative · Tue, 04 Aug 2026 11:00:00 GMTMoleculin Biotech (MBRX) Reports Preliminary Phase 2/3 Trial Dat - GuruFocusGuruFocus · Fri, 31 Jul 2026 13:09:20 GMTBambusa Therapeutics Reports Potentially Transformative Preliminary Proof-of-Concept Results for BBT001 in Atopic Dermatitis, Reinforcing Its Best-in-Disease Potential - PR NewswirePR Newswire · Mon, 27 Jul 2026 10:00:00 GMT